Search

everythinglearnresearchcommunity

for

Search:↓

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Women with thyroid disease are more likely to experience female pattern hair loss, especially if they've had thyroid disease for a long time.

Spironolactone can reduce hair growth in women with hirsutism.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

A new eyelid shampoo improved eyelid hygiene and eyelash length in people with Meibomian Gland Dysfunction.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

Check and treat low iron and vitamin D levels in people with hair loss.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Scalp hair sweating is a significant predictor of hair cortisol levels.

PRP treatment for hair loss shows promise, with 58% of patients satisfied and most noticing improvement within 6 months.

Genetic screening can help diagnose and manage infertility in Slovenian couples.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Mothers have more hair proteins than their children, with age-related differences in protein patterns, and some proteins in hair could indicate early childhood development.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The document suggests medicine should integrate biological and cultural factors and focus on holistic, equitable care.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.